AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2014
Feb 14, 2014
30237_dirs_2014-02-14_760c89c8-a2a6-4478-bba2-368bbd196b03.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2014-02-12
Reporting Person: Boyle James T. Jr. (EVP, Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-12 | Common Stock | M | 2836 | — | Acquired | 31024 | Direct |
| 2014-02-12 | Common Stock | F | 941 | $90.98 | Disposed | 30083 | Direct |
| 2014-02-12 | Common Stock | M | 3333 | — | Acquired | 33416 | Direct |
| 2014-02-12 | Common Stock | F | 1105 | $90.98 | Disposed | 32311 | Direct |
| 2014-02-13 | Common Stock | S | 1895 | $90.29 | Disposed | 30416 | Direct |
| 2014-02-13 | Common Stock | S | 2228 | $90.29 | Disposed | 28188 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-02-12 | Restricted Stock Unit | $ | M | 2836 | Disposed | Common Stock (2836) | Direct | |
| 2014-02-12 | Restricted Stock Unit | $ | M | 3333 | Disposed | Common Stock (3333) | Direct |
Footnotes
F1: Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: Stock withholding to satisfy tax and withholding obligations.
F3: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
F4: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2014.
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 26
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Earnings Release
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Notice of Dividend Amount
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30